Fortive's Net Earnings Plunge on Discontinued Ops, Sales Edge Up

Ticker: FTV · Form: 10-Q · Filed: Oct 29, 2025 · CIK: 1659166

Sentiment: mixed

Topics: Earnings, Spin-off, Restructuring, Cash Flow, Balance Sheet, Discontinued Operations, Strategic Shift

Related Tickers: FTV, RALL

TL;DR

**Fortive's spin-off hit net earnings hard, but continuing operations are holding steady – watch for post-separation growth in their core segments.**

AI Summary

Fortive Corp (FTV) reported a significant decline in net earnings for the three months ended September 26, 2025, falling to $55.0 million from $221.6 million in the prior year, primarily due to a net loss from discontinued operations of $62.0 million compared to a $110.1 million gain in 2024. Despite this, net earnings from continuing operations increased to $117.0 million from $111.5 million. Total sales saw a modest increase to $1,027.1 million from $1,003.7 million year-over-year. For the nine months, net earnings dropped to $393.5 million from $624.1 million, again heavily impacted by discontinued operations. The company completed the separation of its Precision Technologies segment (Ralliant Corporation) on June 28, 2025, which significantly altered its asset and liability structure, including a decrease in total assets from $17,016.1 million to $11,886.7 million. Cash and equivalents decreased from $813.3 million to $430.8 million since December 31, 2024, largely due to $1,345.1 million in common share repurchases and $715.7 million in debt repayments, partially offset by $1,150.0 million from the Ralliant Dividend. A restructuring plan initiated in Q4 2024, related to the PT Separation, incurred $14 million in charges during the nine months ended September 26, 2025, and is extended through the second half of 2026.

Why It Matters

Fortive's strategic shift, marked by the spin-off of Ralliant Corporation, is a critical move for investors, aiming to streamline operations into Intelligent Operating Solutions and Advanced Healthcare Solutions. While continuing operations show resilience with increased net earnings, the substantial impact of discontinued operations on overall net income highlights the transitional risks and the importance of future performance in the new, focused segments. Employees within the divested Precision Technologies segment are now part of Ralliant, while remaining Fortive employees face a refocused corporate strategy. Customers of Fortive's core businesses should see continued innovation, but the competitive landscape in both IOS and AHS remains intense, requiring Fortive to execute flawlessly on its growth initiatives to justify the strategic separation.

Risk Assessment

Risk Level: medium — The risk level is medium due to the significant financial impact of the Precision Technologies Separation, including a $62.0 million net loss from discontinued operations in the quarter and a substantial reduction in total assets from $17,016.1 million to $11,886.7 million. While continuing operations show positive trends, the large-scale restructuring and associated $14 million charges, extended through H2 2026, introduce execution risk and potential for further financial adjustments during this transitional period.

Analyst Insight

Investors should closely monitor Fortive's performance in its core Intelligent Operating Solutions and Advanced Healthcare Solutions segments, focusing on organic growth and profitability metrics post-spin-off. Evaluate the effectiveness of the ongoing restructuring plan and its impact on future operating margins. Consider this a 'wait and see' period for sustained growth in the streamlined entity.

Financial Highlights

revenue
$1,027.1M
operating Margin
15.5%
total Assets
$11,886.7M
total Debt
$3,306.3M
net Income
$55.0M
gross Margin
63.2%
cash Position
$430.8M
revenue Growth
+2.3%

Revenue Breakdown

SegmentRevenueGrowth
Sales of products and software$814.4M+1.5%
Sales of services$212.7M+5.7%

Key Numbers

Key Players & Entities

FAQ

How did Fortive's net earnings change in Q3 2025 compared to the previous year?

Fortive's net earnings for the three months ended September 26, 2025, decreased significantly to $55.0 million from $221.6 million in the same period last year. This 75.2% decline was primarily driven by a net loss from discontinued operations of $62.0 million in Q3 2025, compared to a net gain of $110.1 million in Q3 2024.

What was the impact of the Precision Technologies Separation on Fortive's financial statements?

The Precision Technologies Separation, completed on June 28, 2025, by distributing Ralliant Corporation, significantly impacted Fortive's financials. Total assets decreased from $17,016.1 million as of December 31, 2024, to $11,886.7 million as of September 26, 2025. The company also reclassified cumulative net foreign currency transaction losses of $120 million from Accumulated Other Comprehensive Income (AOCI) into retained earnings.

Did Fortive's continuing operations show growth in sales and earnings?

Yes, Fortive's continuing operations demonstrated growth. Total sales increased to $1,027.1 million for the three months ended September 26, 2025, up from $1,003.7 million in the prior year. Net earnings from continuing operations also rose to $117.0 million from $111.5 million over the same period.

What were Fortive's cash flow activities for the nine months ended September 26, 2025?

For the nine months ended September 26, 2025, Fortive generated $717.3 million in net cash from operating activities. However, it used $79.2 million in investing activities and $1,023.1 million in financing activities. Key financing outflows included $1,345.1 million for common share repurchases and $715.7 million for repayment of borrowings, partially offset by $1,150.0 million from the Ralliant Dividend.

What is the status of Fortive's restructuring plan?

Fortive initiated a discrete restructuring plan in the fourth quarter of 2024, primarily involving workforce reductions related to the PT Separation. This plan, initially expected to conclude by December 31, 2025, has been extended through the second half of 2026. The company incurred $14 million in restructuring charges during the nine months ended September 26, 2025.

How did Fortive's cash and equivalents balance change?

Fortive's cash and equivalents balance decreased by $382.5 million, from $813.3 million at December 31, 2024, to $430.8 million at September 26, 2025. This change was primarily due to significant common stock repurchases and debt repayments, partially mitigated by the Ralliant Dividend proceeds.

What are Fortive's strategic segments after the spin-off?

Following the Precision Technologies Separation, Fortive's strategic segments are Intelligent Operating Solutions (IOS) and Advanced Healthcare Solutions (AHS). These segments focus on essential technologies to keep the world safe and productive, building upon leading brand names and innovative technologies.

What was the change in Fortive's total stockholders' equity?

Fortive's total stockholders' equity decreased from $10,195.6 million as of December 31, 2024, to $6,511.5 million as of September 26, 2025. This significant reduction is largely attributable to the distribution of Ralliant Corporation, which resulted in a $3,283.5 million decrease in retained earnings and a $332.3 million increase in accumulated other comprehensive income (loss) related to the PT Separation.

How did Fortive's debt levels change during the period?

Fortive's current portion of long-term debt increased from $376.2 million at December 31, 2024, to $1,189.2 million at September 26, 2025. Conversely, long-term debt decreased from $3,331.1 million to $2,117.1 million over the same period, reflecting a net repayment of borrowings (maturities greater than 90 days) of $715.7 million during the nine months.

What was the average common stock outstanding for Fortive in Q3 2025?

The average basic common stock outstanding for Fortive for the three months ended September 26, 2025, was 330.8 million shares. This is a decrease from 349.2 million shares in the same period of 2024, reflecting common stock repurchases and the impact of the Ralliant spin-off.

Risk Factors

Industry Context

Fortive operates in diverse industrial technology sectors, including industrial technologies, healthcare, and automation & instrumentation. The company faces competition from established players and specialized niche providers. Trends include increasing demand for automation, digitalization, and sustainable solutions, alongside supply chain complexities and geopolitical uncertainties impacting global manufacturing.

Regulatory Implications

Fortive must comply with financial reporting standards (GAAP) and SEC regulations. The spin-off of its Precision Technologies segment required careful execution to meet regulatory requirements. Ongoing restructuring and potential future acquisitions or divestitures will also be subject to regulatory scrutiny.

What Investors Should Do

  1. Monitor performance of continuing operations closely.
  2. Analyze the impact of share repurchases and debt reduction on liquidity.
  3. Evaluate the ongoing costs and benefits of the PT Separation restructuring.
  4. Assess the increased short-term debt obligations.

Key Dates

Glossary

Discontinued Operations
A component of a business that has been disposed of or is classified as held for sale, and whose operations and cash flows can be separately identified. (The significant net loss from discontinued operations ($62.0M in Q3 2025) heavily impacted Fortive's overall reported net earnings, making it crucial to analyze continuing operations separately.)
Goodwill
An intangible asset that arises when one company acquires another for a price greater than the fair market value of its net assets. (Fortive holds substantial goodwill ($7,276.2M as of Sept 26, 2025), which is subject to impairment testing and could lead to significant write-downs if the acquired businesses underperform.)
Treasury Shares
Stock that a company has repurchased from the open market. (Fortive's treasury shares increased significantly from ($1,612.3M) to ($2,962.6M), reflecting substantial share repurchase activity which reduces outstanding shares and impacts equity.)
Noncontrolling Interests
The portion of equity of a subsidiary that is not attributable to the parent company. (Represents a small portion of Fortive's equity (7.6M as of Sept 26, 2025), indicating minimal ownership by external parties in consolidated subsidiaries.)
Accumulated Other Comprehensive Income (Loss)
A component of equity that includes unrealized gains and losses on certain investments, foreign currency translation adjustments, and pension plan adjustments. (Fortive had a significant swing from a loss of ($465.4M) to a gain of $34.2M, indicating changes in foreign currency translation or other non-operating equity items.)

Year-Over-Year Comparison

Fortive reported a modest 2.3% increase in total sales to $1,027.1 million for Q3 2025 compared to the prior year. However, net income saw a dramatic 75.2% decline to $55.0 million, primarily due to a significant shift from a gain to a loss in discontinued operations. Operating profit from continuing operations showed resilience, increasing slightly, while gross and operating margins remained relatively stable, indicating core business strength despite the overall earnings drop. Total assets have substantially decreased by over $5 billion due to the Precision Technologies separation.

Filing Stats: 4,807 words · 19 min read · ~16 pages · Grade level 7.4 · Accepted 2025-10-29 07:41:56

Key Financial Figures

Filing Documents

- FINANCIAL INFORMATION Page

PART I - FINANCIAL INFORMATION Page

Financial Statements

Item 1. Financial Statements Consolidated Condensed Balance Sheets 4 Consolidated Condensed Statements of Earnings 5 Consolidated Condensed Statements of Comprehensive Income 6 Consolidated Condensed Statements of Changes in Equity 7 Consolidated Condensed Statements of Cash Flows 9 Notes to Consolidated Condensed Financial Statements 10

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 26

Quantitative and Qualitative Disclosures About Market Risk

Item 3. Quantitative and Qualitative Disclosures About Market Risk 37

Controls and Procedures

Item 4. Controls and Procedures 37

- OTHER INFORMATION

PART II - OTHER INFORMATION

Risk Factors

Item 1A. Risk Factors 37

Unregistered Sales of Equity Securities and Use of Proceeds

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 38

Other Information

Item 5. Other Information 38

Exhibits

Item 6. Exhibits 39

Signatures

Signatures 40 3 Table of Contents

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION

FINANCIAL STATEMENTS

ITEM 1. FINANCIAL STATEMENTS FORTIVE CORPORATION AND SUBSIDIARIES CONSOLIDATED CONDENSED BALANCE SHEETS ($ and shares in millions, except per share amounts) (unaudited) As of September 26, 2025 December 31, 2024 ASSETS Current assets: Cash and equivalents $ 430.8 $ 813.3 Accounts receivable less allowance for doubtful accounts of $ 18.7 and $ 19.4 , respectively 633.6 661.3 Inventories: Finished goods 190.8 151.9 Work in process 12.2 15.3 Raw materials 107.6 102.6 Inventories 310.6 269.8 Prepaid expenses and other current assets 303.4 233.6 Current assets, discontinued operations 53.2 614.3 Total current assets 1,731.6 2,592.3 Property, plant and equipment, net of accumulated depreciation of $ 426.5 and $ 392.2 , respectively 258.7 232.9 Other assets 348.6 348.4 Goodwill 7,276.2 7,216.0 Other intangible assets, net 2,268.4 2,530.5 Other assets, discontinued operations 3.2 4,096.0 Total assets $ 11,886.7 $ 17,016.1 LIABILITIES AND EQUITY Current liabilities: Current portion of long-term debt $ 1,189.2 $ 376.2 Trade accounts payable 427.6 425.4 Accrued expenses and other current liabilities 852.7 868.3 Current liabilities, discontinued operations — 568.5 Total current liabilities 2,469.5 2,238.4 Other long-term liabilities 788.6 847.2 Long-term debt 2,117.1 3,331.1 Long-term liabilities, discontinued operations — 403.8 Equity: Common stock: $ 0.01 par value, 2,000 shares authorized; 368.8 and 366.6 issued; 317.6 and 341.2 outstanding, respectively 3.7 3.7 Additional paid-in capital 4,164.3 4,035.0 Treasury shares, at cost ( 2,962.6 ) ( 1,612.3 ) Retained earnings 5,264.3 8,227.6 Accumulated other comprehensive income (loss) 34.2 ( 465.4 ) Total Fortive stockholders' equity 6,503.9 10,188.6 Noncontrolling interests 7.6 7.0 Total stockholders' equity 6,511.5 10,195.6 Total liabilities and equity $ 11,886.7 $ 17,016.1 See the accompanying Notes to Consolidated Condensed Financial Statements. 4 Table of Conte

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing